by Primrose Bio | Nov 26, 2023 | Uncategorized
Ligand signed a purchase and sale agreement with Primrose Bio and made an investment of $15m. 
by Primrose Bio | Sep 19, 2023 | Uncategorized
The cross-pollination of platforms enables the San Diego-based company to create a novel way of enhancing productivity to enable the next generation of biological therapeutics 
by Primrose Bio | Sep 18, 2023 | Uncategorized
SAN DIEGO, Sept. 18, 2023 /PRNewswire/ — Primrose Bio, Inc., a stand-alone private biotechnology company focused on developing state-of-the-art discovery and production systems for protein and nucleic acid medicines, has been established as a...